Prx I Suppresses K-ras-Driven Lung Tumorigenesis by Opposing Redox-Sensitive ERK/Cyclin D1 Pathway

Reactive Oxygen Species in Cancer Stem Cells

(2012) Xiaoke Shi et al.   ANTIOXIDANTS & REDOX SIGNALING

Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs

(2012) V Stresing et al.   ONCOGENE

Proliferative Neural Stem Cells Have High Endogenous ROS Levels that Regulate Self-Renewal and Neurogenesis in a PI3K/Akt-Dependant Manner

(2011) Janel E. Le Belle et al.   Cell Stem Cell

Nitric oxide activates an Nrf2/sulfiredoxin antioxidant pathway in macrophages

(2011) Kahina Abbas et al.   FREE RADICAL BIOLOGY AND MEDICINE

Peroxiredoxin-controlled G-CSF signalling at the endoplasmic reticulum-early endosome interface

(2011) K. Palande et al.   JOURNAL OF CELL SCIENCE

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

(2011) Gina M. DeNicola et al.   NATURE

Nuclear factor E2-related factor 2 Dependent Overexpression of Sulfiredoxin and Peroxiredoxin III in Human Lung Cancer

(2011) Young Sun Kim et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

PIK3CA Mutation Uncouples Tumor Growth and Cyclin D1 Regulation from MEK/ERK and Mutant KRAS Signaling

(2010) E. Halilovic et al.   CANCER RESEARCH

Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol-induced oxidative injury in mouse liver

(2010) Soo Han Bae et al.   HEPATOLOGY

ERK activation drives intestinal tumorigenesis in Apcmin/+ mice

(2010) Sung Hee Lee et al.   NATURE MEDICINE

Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain

(2010) G. Joshi et al.   NEUROSCIENCE

Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity

(2010) F. Weinberg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Peroxiredoxins, a novel target in cancer radiotherapy

(2009) Bo Zhang et al.   CANCER LETTERS

Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer

(2009) S. Homma et al.   CLINICAL CANCER RESEARCH

Use of Protein Tyrosine Phosphatase Inhibitors as Promising Targeted Therapeutic Drugs

(2009) P. Heneberg   CURRENT MEDICINAL CHEMISTRY

Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity

(2009) Juxiang Cao et al.   EMBO JOURNAL

Up-Regulation of Peroxiredoxin 1 in Lung Cancer and Its Implication as a Prognostic and Therapeutic Target

(2008) J.-H. Kim et al.   CLINICAL CANCER RESEARCH

Crucial role of peroxiredoxin III in placental antioxidant defense of mice

(2008) Lianqin Li et al.   FEBS LETTERS

Regulation of Reactive Oxygen Species Homeostasis by Peroxiredoxins and c-Myc

(2008) J. Anthony Graves et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Transcriptional regulation of the cyclin D1 gene at a glance

(2008) E. A. Klein et al.   JOURNAL OF CELL SCIENCE

Peroxiredoxin V Contributes to Antioxidant Defense of Lung Epithelial Cells

(2008) Pedro C. Avila et al.   LUNG

Oncogenic K-Ras Regulates Proliferation and Cell Junctions in Lung Epithelial Cells through Induction of Cyclooxygenase-2 and Activation of Metalloproteinase-9

(2008) Xue-Qing Wang et al.   MOLECULAR BIOLOGY OF THE CELL

Distinct functions of H-Ras and K-Ras in proliferation and survival of primary hepatocytes due to selective activation of ERK and PI3K

(2007) Carola M. Rosseland et al.   JOURNAL OF CELLULAR PHYSIOLOGY